G. Giacomucci

发表

Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14‐year follow‐up study

S. Sorbi, B. Nacmias, S. Bagnoli, 2022, European journal of neurology.

Alzheimer’s Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus

S. Sorbi, B. Nacmias, A. della Puppa, 2022, Journal of personalized medicine.

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment

S. Sorbi, B. Nacmias, V. Berti, 2022, Journal of Neurology.

Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline

A. Mazzoni, S. Sorbi, B. Nacmias, 2022, Neurobiology of Aging.

Gender differences in cognitive reserve: implication for subjective cognitive decline in women

S. Sorbi, B. Nacmias, S. Bagnoli, 2021, Journal of the Neurological Sciences.

Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

S. Sorbi, B. Nacmias, V. Berti, 2021, Journal of personalized medicine.

New Promising Therapeutic Avenues of Curcumin in Brain Diseases

C. Porro, T. Trotta, M. Panaro, 2021, Molecules.

Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

E. Ricci, B. V. van Engelen, J. Vissing, 2020, European journal of neurology.

Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer’s Disease

S. Sorbi, B. Nacmias, V. Berti, 2022, Behavioural Brain Research.

PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10‐year follow‐up study

S. Sorbi, B. Nacmias, S. Bagnoli, 2020, European journal of neurology.

Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients

S. Sorbi, B. Nacmias, S. Bagnoli, 2020, Journal of personalized medicine.

The Effects of Curcumin on Inflammasome: Latest Update

C. Porro, T. Trotta, M. Panaro, 2023, Molecules.

Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer’s Disease

S. Sorbi, B. Nacmias, V. Berti, 2023, Journal of personalized medicine.

Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment

S. Sorbi, B. Nacmias, S. Bagnoli, 2021, Diagnostics.

Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?

S. Micera, A. Mazzoni, S. Sorbi, 2023, NeuroImage: Clinical.

CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study

S. Sorbi, B. Nacmias, S. Bagnoli, 2022, Frontiers in Psychiatry.

The Effect of CAG Repeats within the Non-Pathological Range in the HTT Gene on Cognitive Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

S. Sorbi, B. Nacmias, S. Bagnoli, 2021, Diagnostics.

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol

A. Mazzoni, S. Sorbi, B. Nacmias, 2023, BMC Neurology.

Hidden functional derangement of somatosensory cortices in Alzheimer's Disease.

V. Bessi, G. Giacomucci, 2021, EBioMedicine.

The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment.

B. Nacmias, V. Berti, C. Polito, 2023, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

Plasma neurofilament light chain predicts Alzheimer’s disease in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study

S. Sorbi, B. Nacmias, V. Berti, 2023, medRxiv.

Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study

B. Nacmias, V. Berti, C. Polito, 2023, European Journal of Neurology.

Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia

B. Nacmias, C. Polito, S. Bagnoli, 2024, Cortex.

Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia

B. Nacmias, S. Bagnoli, V. Bessi, 2024, Frontiers in endocrinology.

Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment

B. Nacmias, S. Bagnoli, V. Bessi, 2024, Scientific reports.

Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns

B. Nacmias, C. Polito, S. Bagnoli, 2024, Journal of the Neurological Sciences.

Event-Related Potential Markers of Subject Cognitive Decline and Mild Cognitive Impairment during a sustained visuo-attentive task

B. Nacmias, S. Bagnoli, V. Bessi, 2024, bioRxiv.